Safety and efficacy of eblasakimab, an IL-13R&#206;&#177;1 monoclonal antibody, in adults with moderate-to-severe atopic dermatitis: a phase 1b, multiple-ascending dose study.

eblasakimab (ASLAN004) - ASLAN Pharma, Zenyaku Holdings

http://www.ncbi.nlm.nih.gov/pubmed/37866456

Alexandre Kaoukhov; Andrew Blauvelt; April W Armstrong; Jonathan I Silverberg; Josemund Menezes; Karen A Veverka; Steven T G Thng

Oct 23, 2023